ClassID:

96736

C07K7/06 - page 2 - CPC Classification

Classification description:

Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 5 to 11 amino acids

Recent Application in this class:
#301
20240342290
2024-10-17

Polypeptides having anti-senescent effects and uses thereof

#302
20240342071
2024-10-17

HEXAPEPTIDE,COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE OF HEXAPEPTIDE

#303
20240337665
2024-10-10

IL-17F AND IL-17A-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING

#304
20240336659
2024-10-10

CELL-PENETRATING PEPTIDE, ANTI-CANCER PEPTIDE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SAME

#305
20240336652
2024-10-10

Peptide compounds targeting PD-1 receptor as well as preparation and applications thereof

#306
20240335571
2024-10-10

PRE-TARGETING STRATEGIES FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY

#307
20240327478
2024-10-03

DELIVERY OF CAS9 VIA ARRDC1-MEDIATED MICROVESICLES (ARMMS)

#308
20240327459
2024-10-03

PEPTIDE FRAGMENTS FOR TREATMENT OF DIABETES

#309
20240325560
2024-10-03

COMPOUND FOR THE SEQUESTRATION OF UNDESIRABLE ANTIBODIES IN A PATIENT

#310
20240325448
2024-10-03

COLD ATMOPSHERIC PLASMA TREATED PAN-CANCER EPITOPE PEPTIDE WITHIN THE COLLAGEN TYPE VI A-3 (COL6A3) PROTEIN AS CANCER VACCINE

#311
20240318143
2024-09-26

POST-PROCESSING OF BIOLOGICAL SCAFFOLDS

#312
20240317804
2024-09-26

CELL PENETRATING PEPTIDE

#313
20240309557
2024-09-19

PYRAZOLE AND PYRAZOLINE-CONTAINING PEPTIDES, HIGH THROUGHPUT CLICK LIBRARIES, AND METHODS

#314
20240309045
2024-09-19

NLRP3 INFLAMMASOME INHIBITORY PEPTIDE FOR TREATMENT OF INFLAMMATORY DISEASES

#315
20240307589
2024-09-19

LEPTIN RECEPTOR AFFINITY PEPTIDE AND USE THEREOF

#316
20240307526
2024-09-19

COMPOSITIONS COMPRISING HYDROXYETHYL-CAPPED CATIONIC PEPTOIDS

#317
20240301014
2024-09-12

MICROPEPTIDES AND USE OF SAME FOR MODULATING GENE EXPRESSION

#318
20240301003
2024-09-12

PLASMIN-RESISTANT PEPTIDES FOR IMPROVED THERAPEUTIC INDEX

#319
20240301002
2024-09-12

NOVEL PEPTIDES AND USES THEREOF FOR TREATING CANCER

#320
20240301001
2024-09-12

PEPTIDE-CONTAINING COMPOSITION

#321
20240299599
2024-09-12

DIMERIZATION STRATEGIES AND COMPOUNDS FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY

#322
20240299591
2024-09-12

Antimicrobial Peptides and Their Use

#323
20240299560
2024-09-12

DEOXYCHOLIC ACID-PEPTIDE CONJUGATE HAVING ANTI-OBESITY ACTIVITY AND USE THEREOF

#324
20240294602
2024-09-05

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#325
20240294571
2024-09-05

ANALGESIC AND ANESTHETIC PEPTIDES AND OTHER AGENTS

#326
20240293506
2024-09-05

Immune checkpoint inhibitor combinations

#327
20240287133
2024-08-29

PEPTIDE HAVING ACTIVITY OF PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH, AND USE THEREOF

#328
20240287132
2024-08-29

PEPTIDE, COMPOSITION, AND GHRELIN SECRETION PROMOTING AGENT

#329
20240285780
2024-08-29

PEPTIDE EXHIBITING BOTULINUM TOXIN-LIKE ACTIVITY, AND USE THEREOF

#330
20240285738
2024-08-29

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CLL AND OTHER CANCERS

#331
20240279279
2024-08-22

PROTEIN-DERIVED PEPTIDE FOR IMPROVING IMMUNITY AGAINST 2019 NOVEL CORONAVIRUS (2019-nCoV) AND USE THEREOF

#332
20240279278
2024-08-22

NMU RECEPTOR 2 AGONISTS

#333
20240277861
2024-08-22

ANTI-HEPATITIS B VIRUS AGENT TARGETING HOST FACTOR LIPG

#334
20240271175
2024-08-15

LEADER PEPTIDES AND POLYNUCLEOTIDES ENCODING THE SAME

#335
20240270792
2024-08-15

SHORT ANTIMICROBIAL PEPTIDES

#336
20240270791
2024-08-15

ANTIMICROBIAL PEPTIDES

#337
20240270790
2024-08-15

ANTIGENIC TRIPEPTIDES DERIVED FROM MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS S-TYPE STRAINS, DERIVATIVES AND USES THEREOF

#338
20240269225
2024-08-15

Dry powder formulation of caveolin-1 peptides and methods of use thereof

#339
20240262862
2024-08-08

ANTIMICROBIAL PEPTIDE (AMP) FOR CONTROLLING PSEUDOMONAS SYRINGAE PV. ACTINIDIAE (PSA) AND PREPARATION METHOD AND USE THEREOF

#340
20240261429
2024-08-08

CPMV BINDING PEPTIDE

#341
20240261371
2024-08-08

RHFGF21 FUSION PROTEIN, POLYNUCLEOTIDE ENCODING RHFGF21 FUSION PROTEIN, COMPOSITION CONTAINING RHFGF21 FUSION PROTEIN, AND USE OF RHFGF21 FUSION PROTEIN

#342
20240254166
2024-08-01

COMPOSITIONS AND METHODS FOR INHIBITING AN INFLAMMATORY RESPONSE AND TREATING INFLAMMATORY DISEASES

#343
20240252662
2024-08-01

PEPTIDE DRUG CONJUGATES SPECIFIC TO FIBRONECTIN ISOTYPES FOR CANCER THERAPY

#344
20240248090
2024-07-25

THIOREDOXIN 1 EPITOPE AND MONOCLONAL ANTIBODY SPECIFICALLY BINDING THERETO

#345
20240247080
2024-07-25

GLP1/GIP/NPY2 RECEPTOR TRIPLE AGONISTS

#346
20240247030
2024-07-25

TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES

#347
20240245613
2024-07-25

PEPTIDE LIQUID DROPLETS AND METHODS OF USING THE SAME

#348
20240239904
2024-07-18

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE OR CYSTEINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF

#349
20240239841
2024-07-18

PEPTIDE AND METHOD FOR TREATING PAIN USING THE SAME

#350
20240238451
2024-07-18

SINGLE-DOMAIN ANTIGEN-DEPENDENT ANTIBODY-LIKE FUSION PROTEINS

#351
20240238436
2024-07-18

COMPOSITIONS INCLUDING CONJUGATED THERAPY ENHANCERS

#352
20240230681
2024-07-11

TEMPORAL TRAUMATIC BRAIN INJURY BIOMARKERS AND METHODS OF USE THEREOF

#353
20240228603
2024-07-11

MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF

#354
20240228538
2024-07-11

Novel Peptide Compound Or Pharmaceutically Acceptable Salt Thereof

#355
20240228525
2024-07-11

GLUCOSAMINE DERIVATIVE NANOPARTICLE AND PREPARATING METHOD AND USE THEREOF

#356
20240226232
2024-07-11

PROTEIN-BASED THERAPIES FOR OCULAR CONDITIONS

#357
20240218017
2024-07-04

PEPTIDE AMPHIPHILES WITH MODIFIED DEGRADING SEQUENCES AND METHODS OF USE THEREOF

#358
20240218016
2024-07-04

PEPTIDES AND THEIR USE IN THE TREATMENT OF INFLAMMATION

#359
20240216556
2024-07-04

PEPTIDE-FC FUSIONS FOR TREATING AMYLOID DISORDERS

#360
20240209026
2024-06-27

A4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS

#361
20240209025
2024-06-27

COMPOSITIONS AND METHODS FOR MODULATING GAMMA-C-CYTOKINE ACTIVITY

#362
20240209023
2024-06-27

PEPTIDE COMPOUND, APPLICATION THEREOF AND COMPOSITION CONTAINING SAME

#363
20240209022
2024-06-27

NOVEL PEPTIDE HAVING ANTI-INFLAMMATORY AND TISSUE REGENERATIVE ACTIONS

#364
20240209009
2024-06-27

PEPTIDES COMPRISING A PHOSPHORYLCHOLINE CONJUGATE AND METHODS OF SYNTHESIZING SAME

#365
20240207406
2024-06-27

METHODS AND COMPOSITIONS COMPRISING MHC CLASS I PEPTIDES

#366
20240207162
2024-06-27

CARGO MOLECULE TRANSDUCTION DOMAIN RMAD1, VARIANT THEREOF, RECOMBINANT CARGO MOLECULE, AND METHOD FOR TRANSDUCING CARGO MOLECULE USING SAME

#367
20240207161
2024-06-27

Compositions and method of use for hair straightening and shaping

#368
20240199712
2024-06-20

Zinc-charged peptides for the treatment of cancer and alzheimer's disease

#369
20240199694
2024-06-20

OLIGOPEPTIDE

#370
20240199693
2024-06-20

HEPTAPEPTIDE AMIDES FOR USE IN THE TREATMENT OF HMGB1-DEPENDENT DISEASES

#371
20240199692
2024-06-20

POLYPEPTIDE HAVING MMP2-INHIBITORY EFFECT

#372
20240199687
2024-06-20

SUBSTITUTION OF HISTIDINE WITH 2-THIOHISTIDINE IN BIOACTIVE PEPTIDES

#373
20240192215
2024-06-13

THIOREDOXIN 1 EPITOPE AND MONOCLONAL ANTIBODY SPECIFICALLY BINDING THERETO

#374
20240190919
2024-06-13

PEPTIDE COMPOUNDS AND THERAPEUTIC USES OF SAME

#375
20240190918
2024-06-13

FIBRIL PEPTIDES

#376
20240190917
2024-06-13

Peptides and methods for reducing skin pigmentation

#377
20240190916
2024-06-13

NOVEL PEPTIDE

#378
20240190915
2024-06-13

PEPTIDES FOR THE TREATMENT OF CANCER

#379
20240190914
2024-06-13

METHOD OF TREATING MELANOCORTIN-4 RECEPTOR-ASSOCIATED DISORDERS IN HETEROZYGOUS CARRIERS

#380
20240189385
2024-06-13

KEAP1/NRF2 PROTEIN-LIKE POLYMERS

#381
20240182522
2024-06-06

IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING LUNG CANCER

#382
20240182520
2024-06-06

NEW PEPTIDE-BASED DIAGNOSTIC AND THERAPEUTIC AGENTS

#383
20240182519
2024-06-06

MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN

#384
20240174716
2024-05-30

TRANSPORTER PEPTIDES AND APPLICATION THEREOF

#385
20240174715
2024-05-30

PEPTIDE LIBRARIES WITH NON-CANONICAL AMINO ACIDS

#386
20240173423
2024-05-30

CYCLIC PEPTIDYL INHIBITORS OF CAL-PDZ BINDING DOMAIN

#387
20240166689
2024-05-23

PEPTIDE-COMPOUND CYCLIZATION METHOD

#388
20240166687
2024-05-23

REGULATORY T CELL-INDUCING PEPTIDE AND COMPOSITION INCLUDING SAME FOR PREVENTING OR TREATING AUTOIMMUNE DISEASE

#389
20240166686
2024-05-23

THERAPEUTIC PEPTIDES

#390
20240165247
2024-05-23

NEW PEPTIDE CONJUGATES

#391
20240165245
2024-05-23

MULTIVALENT PEPTOID OLIGOMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SAME

#392
20240158442
2024-05-16

MULTIFUNCTIONAL POLYPEPTIDE AND APPLICATION THEREOF IN FIELD OF MEDICINES

#393
20240158441
2024-05-16

BRANCHED PEPTIDES FOR ENZYMATIC ASSEMBLY AND MITOCHONDRIA DRUG DELIVERY

#394
20240158440
2024-05-16

PEPTIDE AND COMPOSITION CONTAINING PEPTIDE AS ACTIVE INGREDIENT

#395
20240158439
2024-05-16

INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II HLA-DRB1*15:01 MOLECULES WITH ENHANCED METABOLIC STABILITY

#396
20240158438
2024-05-16

POLYPEPTIDE COMPOUND AND APPLICATION THEREOF

#397
20240156982
2024-05-16

METHOD OF FORMING PEPTIDE-COATED NANOPARTICLES

#398
20240156939
2024-05-16

FLAVIVIRUS PEPTIDE SEQUENCES, EPITOPES, AND METHODS AND USES THEREOF

#399
20240150478
2024-05-09

MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AND METHODS OF USE THEREOF

#400
20240150402
2024-05-09

MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVABLE MOIETIES AND METHODS OF USE THEREOF

#401
20240150401
2024-05-09

INSECT NEUROPEPTIDES 7

#402
20240150400
2024-05-09

Insect neuropeptides 6

#403
20240150399
2024-05-09

PROBIOTIC MOLECULES FOR REDUCING PATHOGEN VIRULENCE

#404
20240150398
2024-05-09

PEPTIDES AND CONJUGATES THEREOF AS ACE-2 AND S1 SUBUNIT MIMICS AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV2) INFECTION

#405
20240150397
2024-05-09

Targeted delivery system and methods of use therefor

#406
20240140974
2024-05-02

PLATINUM/PEPTIDE/CUCURBITURIL COMPLESES: WELL-DEFINED ARCHITECTURES BUILT BY SUPRAMOLECULAR SELF-SORTING FOR THE TARGETING OF CYSTEINE PROTEASES

#407
20240133900
2024-04-25

TEMPORAL TRAUMATIC BRAIN INJURY BIOMARKERS AND METHODS OF USE THEREOF

#408
20240132542
2024-04-25

TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS

#409
20240131201
2024-04-25

Compositions that target tumor-associated macrophages and methods of use therefor

#410
20240131113
2024-04-25

PROTEIN-BASED THERAPIES FOR OCULAR CONDITIONS

#411
20240124538
2024-04-18

Modulation of Wnt5a to Treat Glaucoma

#412
20240124521
2024-04-18

NEW PEPTIDES

#413
20240123044
2024-04-18

Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers

#414
20240122959
2024-04-18

COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF

#415
20240116984
2024-04-11

MODIFIED PEPTIDES FOR THE INHIBITION OF ABNORMAL TAU ACCUMULATION

#416
20240116983
2024-04-11

THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS

#417
20240115729
2024-04-11

COMPOSITIONS AND METHODS FOR TARGETED ANTIFIBROTIC THERAPY IN CHRONIC PANCREATITIS

#418
20240115652
2024-04-11

TISSUE OCCLUDING AGENT COMPRISING AN IEIKIEIKIEIKI PEPTIDE

#419
20240109937
2024-04-04

BINDING PEPTIDES AND USES THEREOF

#420
20240108740
2024-04-04

THERAPEUTIC COMPOSITIONS INCLUDING SPN10 AND USES THEREOF

#421
20240101669
2024-03-28

Anti-PVRIG antibodies and methods of use

#422
20240101625
2024-03-28

EPHA2 T-CELL EPITOPE AGONISTS AND USES THEREFORE

#423
20240101618
2024-03-28

IMMUNOMODULATORY PEPTIDE

#424
20240101603
2024-03-28

ANTIBACTERIAL PEPTIDES AND COMPOUNDS TARGETING TOXIN-ANTITOXIN SYSTEM OF KLEBSIELLA PNEUMONIAE, AND THEIR USE

#425
20240101602
2024-03-28

ANTIMICROBIAL PEPTIDES AND METHOD OF PREVENTING OR TREATING INFECTION BY USING THE SAME

#426
20240101601
2024-03-28

BI-TERMINAL PEGYLATED INTEGRIN-BINDING PEPTIDES AND METHODS OF USE THEREOF

#427
20240101600
2024-03-28

FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR)-TARGETING ANTAGONISTIC SHORT PEPTIDE

#428
20240100204
2024-03-28

COMPOSITIONS AND METHODS FOR CANCER IMAGING AND RADIOTHERAPY

#429
20240100194
2024-03-28

ADENO-ASSOCIATED VIRAL VECTOR VARIANTS

#430
20240100137
2024-03-28

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS

#431
20240092835
2024-03-21

NOVEL PEPTIDES CAPABLE OF ALTERING NK CELL ACTIVITY

#432
20240092834
2024-03-21

INHIBITION OF DEGRANULATION OF NEUTROPHIL CELLS IN COVID-19 PATIENTS

#433
20240092833
2024-03-21

PREPARATION OF FUNCTIONAL HOMOCYSTEINE RESIDUES IN POLYPEPTIDES AND PEPTIDES

#434
20240091378
2024-03-21

Compositions and methods of treating ocular diseases

#435
20240091363
2024-03-21

A SENSITIZER- PEPTIDE CONJUGATE

#436
20240091328
2024-03-21

FORMULATIONS AND METHODS FOR MHC-I RESTRICTED EPITOPE IMMUNIZATION

#437
20240084068
2024-03-14

POLYMER COMPOUND COMPRISING PENDENT PEPTIDES, METHOD FOR PREPARING SAME AND USES THEREOF

#438
20240084022
2024-03-14

MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AND METHODS OF USE THEREOF

#439
20240083953
2024-03-14

Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor

#440
20240083951
2024-03-14

Nucleic acids encoding peptides that block binding of a2d-1 to glutamate receptors for treating diseases and disorders

#441
20240083948
2024-03-14

MODIFIED PEPTIDES AND ASSOCIATED METHODS OF USE

#442
20240083947
2024-03-14

PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS

#443
20240083942
2024-03-14

VIRAL VECTOR FOR THE TARGETED TRANSFER OF GENES IN THE BRAIN AND SPINAL CORD

#444
20240083941
2024-03-14

INHIBITORS OF NF KAPPA-B ACTIVITY FOR TREATMENT OF DISEASES AND DISORDERS

#445
20240082409
2024-03-14

Modified peptide ligands for stable delivery of highly potent payloads to tumors: Method of making and using same

#446
20240082346
2024-03-14

Composition Comprising an Antiviral Agent and a CXCR4 Selective Antagonist and Methods For Using the Same

#447
20240076313
2024-03-07

POLYPEPTIDES RV3 AND RV4 HAVING ANTI-AGING FUNCTION AND APPLICATIONS THEREOF

#448
20240075114
2024-03-07

IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOF

#449
20240067677
2024-02-29

Interference Peptides As Inhibitors Of Interactions Related To Ampar Endocytosis

#450
20240067676
2024-02-29

POLYPEPTIDE HAVING ANTI-AGING ACTIVITY, AND APPLICATION THEREOF

#451
20240059736
2024-02-22

Inhibition of pulmonary fibrosis with nutlin-3A and peptides

#452
20240058502
2024-02-22

MEDICAL DEVICE, AND HYDROGEL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

#453
20240051997
2024-02-15

SAP AND PEPTIDOMIMETIC COMPOSITIONS FOR REDUCING SYMPTOMS OF INFLAMMATION

#454
20240051995
2024-02-15

ANTIBACTERIAL AGENTS

#455
20240051994
2024-02-15

RECOMBINANT MICROALGAE ABLE TO PRODUCE KTTKS PEPTIDES, POLYPEPTIDES, OR PROTEINS AND THEIR DERIVATIVES AND ASSOCIATED METHOD AND USES THEREOF

#456
20240050580
2024-02-15

COMPOSITIONS TARGETING TUMOR ASSOCIATED MACROPHAGES AND METHODS USING SAME

#457
20240050543
2024-02-15

CD200 INHIBITORS AND METHODS OF USE THEREOF

#458
20240050364
2024-02-15

IMMUNOSTIMULATORY METHOD

#459
20240043475
2024-02-08

PEPTIDE CONJUGATES

#460
20240043473
2024-02-08

NOOTROPIC PEPTIDES FOR TREATING LYSOSOMAL STORAGE DISEASES

#461
20240042063
2024-02-08

LINKED AND OTHER pH-TRIGGERED COMPOUNDS

#462
20240041973
2024-02-08

ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS

#463
20240034751
2024-02-01

POLYPEPTIDE FOR PREVENTING OR TREATING IDIOPATHIC PULMONARY FIBROSIS AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

#464
20240033364
2024-02-01

CASTRATION RESISTANT PROSTATE CANCER

#465
20240033319
2024-02-01

PEPTIDES FOR PREVENTING OR TREATING HEART AND BLOOD VESSEL DISEASES

#466
20240025973
2024-01-25

PVRIG POLYPEPTIDES AND METHODS OF TREATMENT

#467
20240025965
2024-01-25

Integrin binding peptides and uses thereof

#468
20240025948
2024-01-25

ADHESIVE PEPTIDES

#469
20240024441
2024-01-25

AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

#470
20240018186
2024-01-18

MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND THE USE THEREOF IN THE TREATMENT OF FIBROSIS

#471
20240010680
2024-01-11

PEPTIDE DISINFECTANT FOR PREVENTING CORONAVIRUSES

#472
20240010679
2024-01-11

ANTINOCICEPTIVE COMPOUNDS AND USES THEREOF

#473
20240010678
2024-01-11

METHOD OF TREATMENT OF IRRITABLE BOWEL SYNDROME

#474
20240009257
2024-01-11

METHODS AND MATERIALS FOR TREATING CANCER

#475
20240002896
2024-01-04

PEPTIDE TAG AND TAGGED PROTEIN CONTAINING SAME

#476
20240002439
2024-01-04

PPEPTIDE HAVING PROTECTIVE ACTIVITY AGAINST CELL DAMAGE CAUSED BY PARTICULATE MATTER, AND USES FOR SAME

#477
20230416306
2023-12-28

WAFER LEVEL CHIP SCALE PACKAGE WITH RHOMBUS SHAPE

#478
20230414702
2023-12-28

COMPOUNDS AND PHARMACEUTICAL USE THEREOF IN THE TREATMENT OF CANCER

#479
20230399388
2023-12-14

METHODS FOR TREATING INFLAMMATION USING ANTIBODIES TO KALLIDIN AND DES-ARG10-KALLIDIN

#480
20230399358
2023-12-14

IMMUNOGLOBULIN PURIFICATION PEPTIDES AND THEIR USE

#481
20230391825
2023-12-07

ENHANCED SKIN PERMEATION OF A NOVEL PEPTIDE VIA STRUCTURAL MODIFICATION, CHEMICAL ENHANCEMENT, AND MICRONEEDLES

#482
20230388478
2023-11-30

Imaging systems and methods

#483
20230382964
2023-11-30

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#484
20230374071
2023-11-23

COMPOSITIONS FOR INDUCING URINARY VOIDING AND DEFECATION

#485
20230374070
2023-11-23

AMYLOID-beta AGGREGATION INHIBITOR, PHARMACEUTICAL COMPOSITION FORAMYLOID-beta AGGREGATION DISEASE, AND USE APPLICATION OF SAME

#486
20230374069
2023-11-23

Peptide-based Dopa containing adhesive gels

#487
20230365624
2023-11-16

Angiotensin i-converting enzyme (ACE) inhibitory peptides

#488
20230364212
2023-11-16

Compositions and method for optimized peptide vaccines using residue optimization

#489
20230364210
2023-11-16

ß-AMYLOID VACCINE FOR THE TREATMENT OF ALZHEIMER’S DISEASE

#490
20230357320
2023-11-09

HELICAL STAPLED PEPTIDES AND USES THEREOF

#491
20230355705
2023-11-09

DISCOVERY OF YEATS2 YEATS DOMAIN INHIBITORS AS NOVEL ANTI-CANCER AGENTS

#492
20230355499
2023-11-09

COMPOSITION FOR IMPROVING HAIR HEALTH

#493
20230348563
2023-11-02

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#494
20230348536
2023-11-02

CONJUGATES OF MONTELUKAST AND PEPTIDES

#495
20230347161
2023-11-02

Method and compositions for creating magnetically aligned, bioactive scaffolds for tissue regeneration

#496
20230346981
2023-11-02

ADENO-ASSOCIATED VIRAL VECTOR VARIANTS

#497
20230346960
2023-11-02

PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR

#498
20230346885
2023-11-02

Peptides

#499
20230346837
2023-11-02

PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS

#500
20230340046
2023-10-26

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#501
20230340025
2023-10-26

Treatments for Gastrointestinal Disorders

#502
20230340024
2023-10-26

NOVEL PEPTIDE, COMPOSITIONS AND METHOD FOR DELIVERY OF AGENTS INTO CELLS AND TISSUES

#503
20230338585
2023-10-26

Methods and compositions for visualizing a ureter in a surgical procedure

#504
20230338584
2023-10-26

NOVEL PEPTIDE-BASED CANCER IMAGING AGENTS

#505
20230338489
2023-10-26

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

#506
20230338462
2023-10-26

PHAGE-PEPTIDE CONSTRUCTS FOR STIMULATION OF AN ANTI-CANCER IMMUNE RESPONSE AGAINST CD47

#507
20230332135
2023-10-19

MIRAC PROTEINS

#508
20230331792
2023-10-19

NEW MULTI-FUNCTIONAL OLIGOPEPTIDES

#509
20230331779
2023-10-19

BISPECIFIC FUSION POLYPEPTIDE COMPOUND

#510
20230331778
2023-10-19

AN IMPROVED PROCESS FOR FMOC SYNTHESIS OF ETELCALCETIDE

#511
20230331777
2023-10-19

NOVEL PEPTOID COMPOUNDS THAT BIND TO CELL RECEPTOR ACE2 AND PREVENT VIRUS ENTRY INTO CELLS

#512
20230322886
2023-10-12

RECOMBINANT PROTEIN COMPRISING MULTIPLE MULTI-PEPTIDE SETS, PHARMACEUTICAL COMPOSITION COMPRISING THE RECOMBINANT PROTEIN, AND METHOD FOR PREPARING THE RECOMBINANT PROTEIN

#513
20230322872
2023-10-12

RECOMBINANT PROTEIN COMPRISING MULTIPLE MULTI-PEPTIDE SETS, PHARMACEUTICAL COMPOSITION COMPRISING THE RECOMBINANT PROTEIN, AND METHOD FOR PREPARING THE RECOMBINANT PROTEIN

#514
20230322855
2023-10-12

Anti-allergic peptide and use thereof for immune regulation and anti-allergy

#515
20230322854
2023-10-12

HUNTINGTIN-RELATED PEPTIDE AGENTS AND USES THEREOF

#516
20230312652
2023-10-05

NOVEL PEPTIDES AND USES THEREOF

#517
20230312648
2023-10-05

PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE DISEASES

#518
20230312646
2023-10-05

ANTIBACTERIAL PEPTIDES

#519
20230310702
2023-10-05

SELF-ASSEMBLING PEPTIDES, PREPARATION METHODS, SELF-ASSEMBLING PEPTIDE FORMULATIONS AND USE

#520
20230310625
2023-10-05

Peptide oligonucleotide conjugates

#521
20230309566
2023-10-05

BIOACTIVE PEPTIDES HAVING DETRIMENTAL EFFECTS ON PEST SLUGS

#522
20230303656
2023-09-28

CLAUDIN-18.2-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES

#523
20230295659
2023-09-21

TARGETING PEPTIDES FOR DIRECTING ADENO-ASSOCIATED VIRUSES (AAVs)

#524
20230295233
2023-09-21

POLYPEPTIDE FOR REPAIRING MUCOSAL DAMAGE OR SKIN WOUND AND USE THEREOF

#525
20230295232
2023-09-21

Solution phase routes for WNT hexapeptides

#526
20230295231
2023-09-21

Short Proline Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug- and Extensively Drug-Resistant Pseudomonas Aeruginosa

#527
20230295230
2023-09-21

TRANSMEMBRANE BETA BARREL PROTEINS

#528
20230295229
2023-09-21

PEPTIDE SELECTIVELY BINDING TO CANCER CELL-DERIVED EXOSOME, AND USES THEREOF

#529
20230288421
2023-09-14

SARS-COV-2 SERUM ANTIBODY PROFILING

#530
20230288408
2023-09-14

NOVEL PEPTIDE TAG

#531
20230287069
2023-09-14

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#532
20230287054
2023-09-14

CHIMERIC POLYPEPTIDES AND USES THEREOF

#533
20230287045
2023-09-14

METHODS FOR ASSEMBLING PEPTIDES INTO PEPTIDE AMPHIPHILE NANOFIBERS

#534
20230287044
2023-09-14

NOVEL ANTIBACTERIAL PEPTIDE AND USE THEREOF

#535
20230285501
2023-09-14

Saposin-A derived peptides and uses thereof

#536
20230285462
2023-09-14

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

#537
20230285461
2023-09-14

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

#538
20230285460
2023-09-14

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

#539
20230285458
2023-09-14

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

#540
20230279460
2023-09-07

METHOD FOR RAPID IN VITRO SYNTHESIS OF GLYCOPROTEINS VIA RECOMBINANT PRODUCTION OF N-GLYCOSYLATED PROTEINS IN PROKARYOTIC CELL LYSATES

#541
20230279344
2023-09-07

AIR-LOADED GAS VESICLE NANOPARTICLES FOR PROMOTING CELL GROWTH IN 3D BIOPRINTED TISSUE CONSTRUCTS

#542
20230279069
2023-09-07

FORMULATION OF MODIFIED INTERLEUKIN-7 FUSION PROTEIN

#543
20230279066
2023-09-07

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#544
20230279045
2023-09-07

Methods and systems for solid phase peptide synthesis

#545
20230277641
2023-09-07

TELOMERASE POLYPEPTIDE VACCINE FOR TREATING CANCER

#546
20230276788
2023-09-07

Compositions and methods for reducing ice crystal formation

#547
20230272006
2023-08-31

PEPTIDOMIMETICS AND METHOD OF SYNTHESIS THEREOF

#548
20230272004
2023-08-31

RAMP TAG FOR INSULIN OVEREXPRESSION AND METHOD FOR MANUFACTURING INSULIN USING SAME

#549
20230270856
2023-08-31

FUSION PROTEIN AND USE THEREOF

#550
20230265158
2023-08-24

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#551
20230263873
2023-08-24

PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS

#552
20230263830
2023-08-24

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

#553
20230258569
2023-08-17

REAGENT FOR MEASURING SKIN SENSITIZATION, COMPOUND, AND METHOD FOR MEASURING SKIN SENSITIZATION

#554
20230257421
2023-08-17

CBX8 chromdomain inhibitors and the uses thereof

#555
20230257420
2023-08-17

COMPOUNDS FOR DRUG DELIVERY ACROSS BLOOD-BRAIN BARRIER

#556
20230257419
2023-08-17

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING A PERIODONTAL DISEASE OR DISLOCATED TRAUMATIC TOOTH

#557
20230248840
2023-08-10

ALBUMIN BINDING PEPTIDE CONJUGATES AND METHODS THEREOF

#558
20230248769
2023-08-10

IMMUNOGENIC PEPTIDES SPECIFIC TO BCMA AND TACI ANTIGENS FOR TREATMENT OF CANCER

#559
20230248630
2023-08-10

Cell-penetrating peptides and composition including the same

#560
20230242604
2023-08-03

B*44 restricted peptides for use in immunotherapy against cancers and related methods

#561
20230242583
2023-08-03

PROTEOGENOMIC-BASED METHOD FOR IDENTIFYING TUMOR-SPECIFIC ANTIGENS

#562
20230242582
2023-08-03

NOVEL ALPHA-HELICAL DOUBLE-SIDED CELL PENETRATING PEPTIDE AND USE THEREOF

#563
20230242581
2023-08-03

SYNTHESIS OF A GUANYLATE CYCLASE AGONIST BY FRAGMENTS BASED APPROACH

#564
20230242572
2023-08-03

a-CARBONYL ALKENYL ESTER PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#565
20230241115
2023-08-03

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

#566
20230241114
2023-08-03

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

#567
20230241113
2023-08-03

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

#568
20230241112
2023-08-03

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

#569
20230241111
2023-08-03

Immunotherapy against neuronal and brain tumors

#570
20230241110
2023-08-03

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

#571
20230241109
2023-08-03

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

#572
20230241108
2023-08-03

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

#573
20230241107
2023-08-03

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

#574
20230241106
2023-08-03

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

#575
20230235016
2023-07-27

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#576
20230235015
2023-07-27

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#577
20230235014
2023-07-27

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#578
20230234986
2023-07-27

INHIBITORS OF CORONAVIRUS PROTEASE

#579
20230233704
2023-07-27

HYDROGEL COMPOSITION AND ASSOCIATED METHOD OF USE

#580
20230233612
2023-07-27

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

#581
20230227694
2023-07-20

ANTI-VIRAL COATING COMPOSITION, AND METHOD FOR FIXING ANTI-VIRAL FUSION PROTEIN TO SURFACES

#582
20230227576
2023-07-20

RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY

#583
20230227517
2023-07-20

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS

#584
20230227503
2023-07-20

POLYPEPTIDE EXPRESSED IN THE STRATUM CORNEUM AND USE THEREOF

#585
20230227501
2023-07-20

Peptide having cytoprotective effect against environmental pollutant and use thereof

#586
20230227500
2023-07-20

NANOPARTICLE-LIKE DELIVERY SYSTEM

#587
20230226162
2023-07-20

A*03 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS

#588
20230226161
2023-07-20

CCR8 peptide and T cells for use in immunotherapeutic treatment of various cancers

#589
20230226140
2023-07-20

ANG (1-7) DERVIATIVE OLIGOPEPTIDES FOR THE TREATMENT OF PAIN

#590
20230226139
2023-07-20

PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH

#591
20230220010
2023-07-13

BROAD-SPECTRUM ANTIVIRAL PEPTIDES

#592
20230220006
2023-07-13

REGENTIDE-034 AND COMPOSITION FOR IMPROVING CONDITION OF SKIN, CONTAINING SAME

#593
20230220005
2023-07-13

S100A8-INHIBITING PEPTIDE AND DISEASE THERAPEUTIC AGENT CONTAINING SAME

#594
20230220004
2023-07-13

POLYPEPTIDE TAG AND APPLICATION THEREOF IN IN VITRO PROTEIN SYNTHESIS

#595
20230218708
2023-07-13

Compositions and methods of targeting cancer stem cells

#596
20230212223
2023-07-06

Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosis

#597
20230212222
2023-07-06

COMPOSITION FOR ANTI-DIABETES AND ANTI-OBESITY COMPRISING NOVEL COMPOUND

#598
20230211022
2023-07-06

RADIOTHERAPEUTIC AND COMPANION IMAGING AGENTS TO TARGET MC1R

#599
20230210748
2023-07-06

COMPOSITION COMPRISING REGENTIDE-034 AND REGENTIDE-041 FOR SKIN CARE OR WRINKLE REDUCTION

#600
20230203203
2023-06-29

Neutrophil-binding peptides